More Patients and Medical Articles

Patients and Medical

Patient centricity: Mind the capacity gap

Lucy Fulford, (Jul 21, 2020)

If pharma wants patients and patient groups capable of working with it at every stage of the drug development process it must listen to, and contribute to training and funding them
Patients and Medical

What patients need right now

Andrew Stone, (Jul 7, 2020)

In the face of massive patient need, there’s plenty pharma can do to help. The crisis is also an opportunity for it to transform the way it works with patients.
Patients and Medical

The emerging patient-centricity landscape in Japan

Lucy Fulford, (Jun 9, 2020)

Change is happening in patient engagement as Japan's pharma pioneers begin to lay strong foundations for a richer future
Patients and Medical

Building a bridge to a COVID-19 vaccine

Andrew Stone, (Apr 15, 2020)

Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual
Patients and Medical

How should pharma approach patient collaboration in the 2020s?

Lucy Fulford, (Apr 1, 2020)


Deeper, more holistic, strategic and ‘patient directed’ engagement will be a win for all this coming decade
Patients and Medical

Patients and RWE: Is this the year?

Tom Disley, (Mar 26, 2020)

There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen
Patients and Medical

Advancing through partnerships

Andrew Stone, (Mar 14, 2020)

Collaboration makes sense on many fronts on our journey to sustainably improve the lives of patients, says Merck’s Chris Round
Patients and Medical

Online hospitals – the journey from East to West

Katie Osborne, (Mar 13, 2020)

Artificial intelligence and digital are already transforming medical service delivery in China and it’s heading west rapidly
Patients and Medical

Building an innovation culture

Andrew Stone, (Mar 12, 2020)

Without the right approach to risk and culture, pharma may miss the big opportunities, says Bayer’s Sebastian Guth
Access and Evidence

Into pharma's roaring twenties

Paul Simms, (Jan 14, 2020)

A new decade is here. And despite the incredible science, pharma is ill-equipped.

Pages